| TME | Tumor microenvironment |
| MSCs | Mesenchymal stem cells |
| CAFs | Cancer-associated fibroblasts |
| CSCs | cancer stem cells |
| NK | natural killer |
| TEXs | Tumor-derived exosomes |
| TAAs | Tumor-associated antigens |
| HCC | human hepatocellular carcinoma |
| ECA | esophageal carcinoma tissue |
| KIRs | killer immunoglobulin receptors |
| NCRs | natural cytotoxicity receptors |
| AML | acute myelogenous leukaemia |
| TAMs | Tumor-associated macrophages |
| EGCG | epigallocatechin gallate |
| DDS | drug delivery systems |
| PAC | paclitaxel |
| TRCs | tumor-repopulating cells |
| CTCs | circulating tumor cells |
| PTC | papillary thyroid cancer |
| CRC | colorectal cancer |
| HSP70 | heat shock protein 70 |
| TSP1 | platelet-reactive protein 1 |
| LDH-C4 | lactate dehydrogenase C4 |
| FDA | Food and Drug Administration |
| PPIs | proton-pump inhibitors |
| GC | gastric cancer |
| PC | pancreatic cancer |
| HSPGs | Heparan sulfate proteoglycans |
| NPC | nasopharyngeal carcinoma |
| FGF | fibroblast growth factor |
| GC-Exos | Gastric cancer cell-derived exosomes |
| CAFs | Carcinoma-associated fibroblasts |